Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariella Kelman

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The Journal of Rheumatology|March 3, 2010
Efficacy and safety of retreatment in patients with rheumatoid arthritis with previous inadequate response to tumor necrosis factor inhibitors: results from the SUNRISE trialPhilip J Mease, Stanley Cohen, Norman B Gaylis, et al.
Arthritis and Rheumatism|December 30, 2009
Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trialClifton O Bingham, R John Looney, Atul Deodhar, et al.
The Journal of Rheumatology|January 30, 2010
Longterm safety of patients receiving rituximab in rheumatoid arthritis clinical trialsRonald F van Vollenhoven, Paul Emery, Clifton O Bingham, et al.
Arthritis and Rheumatism|December 1, 2011
Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatmentPreeti Lal, Zheng Su, Cecile T J Holweg, et al.
Journal of Crohn'S & Colitis|April 17, 2025
Drug tissue concentration and STAT3 modulation as determinants of tofacitinib response in ulcerative colitisBram Verstockt, Dahham Alsoud, Joep van Oostrom, et al.
Science Translational Medicine|September 23, 2011
A plasmablast biomarker for nonresponse to antibody therapy to CD20 in rheumatoid arthritisKasia Owczarczyk, Preeti Lal, Alexander R Abbas, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Journal of Rheumatology|March 3, 2010
Efficacy and safety of retreatment in patients with rheumatoid arthritis with previous inadequate response to tumor necrosis factor inhibitors: results from the SUNRISE trialPhilip J Mease, Stanley Cohen, Norman B Gaylis, et al.
Arthritis and Rheumatism|December 30, 2009
Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trialClifton O Bingham, R John Looney, Atul Deodhar, et al.
The Journal of Rheumatology|January 30, 2010
Longterm safety of patients receiving rituximab in rheumatoid arthritis clinical trialsRonald F van Vollenhoven, Paul Emery, Clifton O Bingham, et al.
Arthritis and Rheumatism|December 1, 2011
Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatmentPreeti Lal, Zheng Su, Cecile T J Holweg, et al.
Journal of Crohn'S & Colitis|April 17, 2025
Drug tissue concentration and STAT3 modulation as determinants of tofacitinib response in ulcerative colitisBram Verstockt, Dahham Alsoud, Joep van Oostrom, et al.
Science Translational Medicine|September 23, 2011
A plasmablast biomarker for nonresponse to antibody therapy to CD20 in rheumatoid arthritisKasia Owczarczyk, Preeti Lal, Alexander R Abbas, et al.
Pageof 2